Correlation Between Allarity Therapeutics and Immix Biopharma
Can any of the company-specific risk be diversified away by investing in both Allarity Therapeutics and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allarity Therapeutics and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allarity Therapeutics and Immix Biopharma, you can compare the effects of market volatilities on Allarity Therapeutics and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allarity Therapeutics with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allarity Therapeutics and Immix Biopharma.
Diversification Opportunities for Allarity Therapeutics and Immix Biopharma
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Allarity and Immix is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Allarity Therapeutics and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and Allarity Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allarity Therapeutics are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of Allarity Therapeutics i.e., Allarity Therapeutics and Immix Biopharma go up and down completely randomly.
Pair Corralation between Allarity Therapeutics and Immix Biopharma
Given the investment horizon of 90 days Allarity Therapeutics is expected to under-perform the Immix Biopharma. In addition to that, Allarity Therapeutics is 1.11 times more volatile than Immix Biopharma. It trades about -0.27 of its total potential returns per unit of risk. Immix Biopharma is currently generating about -0.04 per unit of volatility. If you would invest 528.00 in Immix Biopharma on August 24, 2024 and sell it today you would lose (360.00) from holding Immix Biopharma or give up 68.18% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 99.6% |
| Values | Daily Returns |
Allarity Therapeutics vs. Immix Biopharma
Performance |
| Timeline |
| Allarity Therapeutics |
| Immix Biopharma |
Allarity Therapeutics and Immix Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Allarity Therapeutics and Immix Biopharma
The main advantage of trading using opposite Allarity Therapeutics and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allarity Therapeutics position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.| Allarity Therapeutics vs. Immix Biopharma | Allarity Therapeutics vs. Cns Pharmaceuticals | Allarity Therapeutics vs. Sonnet Biotherapeutics Holdings | Allarity Therapeutics vs. Zura Bio Limited |
| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |